-
Check4Cancer’s Professor Gordon Wishart in the media discussing the impact of coronavirus on cancer diagnosis and treatment
Professor Gordon Wishart, Chief Medical Officer and CEO at Check4Cancer, a leading early cancer detection and cancer prevention company, was interviewed on The Today Programme on BBC Radio 4 this morning, discussing the impact of the coronavirus pandemic on cancer diagnosis and treatment. Prof Wishart explained that patients with different types of cancer are experiencing…
-
Check4Cancer launches new London ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics
London, UK, 31st March 2020 / Sciad Newswire / Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, launches a private ‘OneStop Breast Clinic’ for younger patients who will no longer be seen in NHS breast clinics. Many people will not be aware that one of the effects of the COVID-19 outbreak is that NHS outpatient capacity has been drastically reduced…
-
New analysis confirms value of investing public money to commercialise public science
London, UK, 30th March 2020 / Sciad Newswire / The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support have generated benefits for early stage companies and for the UK economy as a whole. The report, by economic research specialists SQW Consulting, demonstrates the unique value…
-
Food Glorious Food! COVID-19: We will get through this together (26th March 2020)
In this blog I will share my experiences and thoughts over the next weeks and months. I also want to tell your stories, so I am asking staff members across the NHS to send me your uplifting anecdotes and photos because, if we pull together and support our peers, we will get through this. Please send your…
-
Communicating with consideration in this crisis
We all worry about the unknown, and have done long before COVID-19, so it’s important to remind ourselves to worry about what is happening in reality, rather than what is in our minds. With such a dangerous disease and an unprecedented response from Government to lessen the impact and avert disaster, my mind is in…
-
A surgical mask but no helmet? COVID-19: we will get through this together! (23rd March 2020)
In this blog I will share my experiences and thoughts over the next weeks and months. I also want to tell your stories, so I am asking staff members across the NHS to send me your uplifting anecdotes and photos because, if we pull together and support our peers, we will get through this. Please send your…
-
Startups against coronavirus! Platform brings startups and companies together for solving critical challenges
Startups can share solutions on startupsagainstcorona.com, published today, for acute challenges that companies face because of the COVID-19 pandemic. The platform is an offer from the Venture Client services provider 27pilots, that organizes cooperations with startups for companies like the BMW Group or the BSH Hausgeräte GmbH. Munich, Germany, 19th March 2020 / Sciad Newswire / Practical support for companies in…
-
COVID-19: we will get through this together!
For doctors, nurses and allied health professional in the NHS life has suddenly changed. We’re spending our time pre-occupied with preparations for the COVID-19 pandemic. Cancelling elective work, converting clinics to telephone only, finding room for extra ITU capacity. It’s extraordinary and beyond any of our experience. I’m also a husband, a father and a…
-
GyreOx announces seed funding to develop novel therapeutics targeting intracellular proteins implicated in cancer and autoimmune diseases
Harwell, UK, 11th March 2020 / Sciad Newswire / GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing from UKI2S and LifeArc. Developing complex molecules able to target intracellular interactions, the company will develop therapy for cancer and autoimmune diseases based on research carried out by Professor James Naismith (University of Oxford, previously at the University…
-
Living longer extends lifetime consumption of medicines: Can pharma meet the challenge by making drugs more efficiently?
Falmouth, UK, 11th March 2020 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG): The pharmaceutical industry is facing a challenge partly of its own making. So effective have the industry’s products been at extending people’s lives that the total cost of medicine consumption is stretching the limits of affordability around the world. To consider how pharmaceutical companies can respond,…